Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Short Interest Up 27.2% in January
Ocean Bio-Chem, Inc. (NASDAQ:OBCI) was the target of a surge in short interest during the month of January. As of January 15, there was short interest totaling 57,500 shares, an increase of 27.2% from the total of 45,200 shares as of December 31. Based on an average trading volume of 9,800 shares, the short interest ratio is currently 5.9 days. Currently, 1.6% of the company’s shares are sold short.
A number of institutional investors and hedge funds have recently increased or reduced their stakes in the company. Ancora Advisors LLC increased its stake in Ocean Bio-Chem by 3.0% in the 2nd quarter. Ancora Advisors LLC now owns 128,334 shares of the company valued at $1,566,000 after purchasing an additional 3,734 shares in the last quarter. BlackRock Inc. increased its holdings in Ocean Bio-Chem by 637.3% in Q3. BlackRock Inc. now owns 10,846 shares of the company valued at $102,000 after purchasing an additional 9,375 shares in the last quarter. Citadel Advisors LLC acquired a new stake in Ocean Bio-Chem in Q3 worth approximately $93,000. Stifel Financial Corp acquired a new stake in Ocean Bio-Chem in Q2 worth approximately $162,000. Finally, AltraVue Capital LLC increased its stake in Ocean Bio-Chem by 55.2% in the 2nd quarter. AltraVue Capital LLC now owns 94,996 shares of the company valued at $1,159,000 after purchasing an additional 33,772 shares in the last quarter. 9.00% of the shares are currently held by hedge funds and other institutional investors.
Shares of NASDAQ OBCI opened at $9.68 on Thursday. The company has a debt ratio of 0.17, a quick ratio of 3.95 and a current ratio of 6.12. The company has a market capitalization of $91.82 million, a price-earnings ratio of 10.76 and a beta of 0.34. The company’s 50-day moving average is $8.88. Ocean Bio-Chem has a 52 week low of $7.85 and a 52 week high of $15.21.
Ocean Bio-Chem (NASDAQ:OBCI) last released its results on Monday, November 15. The company reported earnings per share (EPS) of $0.34 for the quarter. The company had revenue of $21.48 million for the quarter. Ocean Bio-Chem had a return on equity of 20.11% and a net margin of 13.70%.
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 21. Shareholders of record on Monday, December 6 received a dividend of $0.03. This represents a dividend of $0.12 on an annualized basis and a yield of 1.24%. The ex-dividend date was Friday, December 3. Ocean Bio-Chem’s dividend payout ratio (DPR) is currently 13.33%.
About Ocean Bio-Chem
Ocean Bio-Chem, Inc. manufactures, markets and distributes appearance, performance and care products under the Star brite and Star Tron brand names. The company also manufactures and distributes disinfectant, sanitizer and deodorant products under the Performacide and Star brite brands. It serves the marine, automotive, powersports, recreational vehicles and outdoor power equipment markets.
Read more: How does the Beige Book influence monetary policy?
This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in Ocean Bio-Chem right now?
Before you consider Ocean Bio-Chem, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Ocean Bio-Chem didn’t make the list.
Although Ocean Bio-Chem currently has an “N/A” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here